| Bioactivity | ABTL-0812 (α-Hydroxylinoleic acid) induces endoplasmic reticulum (ER) stress-mediated autophagy. ABTL-0812 is a first-in-class small molecule with anti-cancer activity[1]. | ||||||||||||
| Invitro | ABTL-0812 (ABTL0812; 10-100 μM; 48 hours) inhibits cell viability of squamous NSCLC H157 cells[1].Compared with squamous NSCLC H157 cells, human lung fibroblast cell line MRC-5 are resistant to ABTL0812 treatment[1]. Cell Viability Assay[1] Cell Line: | ||||||||||||
| Name | ABTL-0812 | ||||||||||||
| CAS | 57818-44-7 | ||||||||||||
| Formula | C18H32O3 | ||||||||||||
| Molar Mass | 296.44 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
ABTL-0812
CAS: 57818-44-7 F: C18H32O3 W: 296.44
ABTL-0812 (α-Hydroxylinoleic acid) induces endoplasmic reticulum (ER) stress-mediated autophagy. ABTL-0812 is a first-i
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.